Browse Primary Care/Hospitalist Articles by Topic

No Antibiotic Prescription Required

Acquisition of antibiotics without a prescription can be easy in the United States.

CRP and Reduction of Antibiotic Use in Acute Exacerbations of COPD

Point-of-care C-reactive protein testing can safely and effectively reduce antibiotic use in patients with acute exacerbations of COPD.

Treating Infective Endocarditis in Moderate-Risk Patients

There are patients with a moderate risk of infective endocarditis who may warrant consideration of antibiotic prophylaxis.

Calcitonin Gene-Related Peptide Targeting Therapies for Migraine

Two randomized clinical trials showed that calcitonin gene-related peptide targeting therapies are effective and safe for primary headache disorders.

Are the Changes New, Recent, or Old?

Imagine examining the ECG in the figure below without any accompanying clinical information. How would one interpret this tracing? What might one suspect is going on?

Imipenem, Cilastatin, and Relebactam Injection (Recarbrio)

The FDA has approved a new antibacterial drug combination for complicated urinary tract infections and complicated intra-abdominal infections.

Hot Beverages and Esophageal Cancer

In a cohort of more than 50,000 people, there was a higher risk of esophageal squamous cell carcinoma in those who consumed higher quantities of mostly black tea at hotter temperatures.

Reducing Mortality in Stable Ischemic Heart Disease Patients

A multivariate analysis of a large registry of patients with stable ischemic heart disease revealed that beta-blocker use was associated with lower mortality only when prescribed in the first year after acute myocardial infarction.

Atorvastatin: What Is Good for the Heart Is Good for the Kidneys

For patients at risk of or who already have been diagnosed with cardiovascular disease and are taking atorvastatin, an added benefit is improved kidney function in a dose-dependent manner.

New Tool May Identify People at Risk for HIV

A potential analytical tool may help providers identify those at risk for HIV in efforts to offer pre-exposure prophylaxis (PrEP). Using a machine-learning algorithm to predict who could become infected with HIV during a three-year period, researchers were able to flag 2.2% of 3.7 million patients as high or very high risk.